Published in J Thorac Imaging on March 01, 2015
National Lung Screening Trial (NLST) Screening (NLST) | NCT00047385
Risk factors assessment and risk prediction models in lung cancer screening candidates. Ann Transl Med (2016) 0.75
Implementing lung cancer screening in the real world: opportunity, challenges and solutions. Transl Lung Cancer Res (2015) 0.75
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med (2014) 7.39
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26
Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA (2003) 4.81
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ (1997) 4.43
Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol (2010) 4.15
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med (2014) 3.57
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care (2007) 3.56
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
United States life tables, 2009. Natl Vital Stat Rep (2014) 1.89
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer (2014) 1.80
The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer (2013) 1.76
Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res (2006) 1.64
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56
Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen (2008) 1.48
Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen (2012) 1.46
An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) (2012) 1.45
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer (2009) 1.44
The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest (2003) 1.38
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer (2005) 1.29
Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer (2001) 1.15
Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol (2014) 1.03
Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography. Clin Lung Cancer (2012) 0.94
Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J (2010) 0.91
Adjusting for bias in C/E ratio estimates. Health Econ (1997) 0.90
Screening for lung cancer: moving into a new era. Ann Intern Med (2013) 0.85
Nonmedical costs of colorectal cancer screening using CT colonography. J Am Coll Radiol (2010) 0.79